R&D The rise and market race of anti-IL23p19 therapies in IBD: H... The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two decades.
R&D Into the bowels of gut research For people living with Inflammatory Bowel Disease (IBD), navigating life around the risk of flare-ups can be a messy and exhausting challenge.
R&D Highlights & Headlines from Deep Dive: R&D pharmaphorum’s Deep Dive magazine is back to explore trends, challenges, & innovations in R&D.
News Sanofi, CytoReason expand AI deal into IBD Tech company CytoReason has announced it has signed a multi-year, multimillion dollar deal with Sanofi to deliver artificial intelligence (AI) for drug discovery and development in the fiel
Digital How digital pathways are changing healthcare As demonstrated throughout COVID, digital health is no longer experimental.
Events Partner Content PREDiCT: Autoimmune Disease Modeling Summit Deploy Advanced Models to Enhance Your Confidence & Und
News 'Trust gap' is holding back AI in healthcare The potential for AI to help tackle bottlenecks in healthcare is being held back by patient scepticism and doctor concerns about bias and liability.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
